vitamin k 3 has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Beebe, J | 1 |
Josephraj, S | 1 |
Wang, CJ | 1 |
Danielson, J | 1 |
Cui, Q | 1 |
Huang, C | 1 |
Barlow, L | 1 |
Zhang, RH | 1 |
Zhang, T | 1 |
Nakshatri, H | 1 |
Dong, Z | 1 |
Li, X | 1 |
Liu, JY | 1 |
Zhang, JT | 1 |
Bohl, L | 1 |
Guizzardi, S | 1 |
RodrÃguez, V | 1 |
Hinrichsen, L | 1 |
Rozados, V | 1 |
Cremonezzi, D | 1 |
Tolosa de Talamoni, N | 1 |
Picotto, G | 1 |
Yamada, A | 1 |
Osada, S | 1 |
Tanahashi, T | 1 |
Matsui, S | 1 |
Sasaki, Y | 1 |
Tanaka, Y | 1 |
Okumura, N | 1 |
Matsuhashi, N | 1 |
Takahashi, T | 1 |
Yamaguchi, K | 1 |
Yoshida, K | 1 |
3 other studies available for vitamin k 3 and ER-Negative PR-Negative HER2-Negative Breast Cancer
Article | Year |
---|---|
Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase.
Topics: Fatty Acid Synthases; Humans; Lansoprazole; Lipids; Oxidoreductases; Proton Pump Inhibitors; Sulfide | 2022 |
Combined calcitriol and menadione reduces experimental murine triple negative breast tumor.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Calcium; Cell Nucleus; DNA Frag | 2017 |
Novel therapy for locally advanced triple-negative breast cancer.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Extracellul | 2015 |